Recent News

• 09.17.2025 - Sight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI® Surgical System Achieves Clinically Significant, Long-Term Reductions in IOP and Medication Use
• 09.17.2025 - Sight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI® Surgical System Achieves Clinically Significant, Long-Term Reductions in IOP and Medication Use
• 09.10.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.10.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.09.2025 - Sight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare’s® Expanded Coverage of Glaucoma Surgical Treatments
• 09.09.2025 - Sight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare’s® Expanded Coverage of Glaucoma Surgical Treatments
• 09.02.2025 - Sight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO
• 09.02.2025 - Sight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO
• 08.26.2025 - Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
• 08.26.2025 - Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference

Recent Filings

• 09.16.2025 - 144 Report of proposed sale of securities
• 09.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.12.2025 - 144 Report of proposed sale of securities
• 09.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.27.2025 - 8-K Current report